Five Years On, AlphaFold Shows Why Science May Be AI's Killer App

Five years after AlphaFold first solved the protein structure prediction problem, the technology has become what may be artificial intelligence's most consequential real-world application. Used by over 3 million researchers across more than 190 countries, AlphaFold has fundamentally changed how biological research is conducted.

The impact spans from basic science to applied medicine. Researchers are using AlphaFold to understand the molecular basis of diseases, design new therapeutics, develop novel antibiotics to combat antimicrobial resistance, and even create synthetic enzymes for environmental applications. The AlphaFold Protein Structure Database, which provides free access to predicted structures for nearly all known proteins, has become essential infrastructure for the life sciences.

AlphaFold 3, released in 2024, extended predictions beyond individual proteins to model how proteins interact with DNA, RNA, and small molecules — capabilities directly relevant to drug design. This expansion has made the tool even more valuable for pharmaceutical research, where understanding molecular interactions is fundamental to developing effective therapies.

The story of AlphaFold also illustrates broader questions about AI's role in society. Unlike many AI applications that have generated controversy, AlphaFold is widely regarded as an unambiguous positive — a technology that has democratized access to structural biology knowledge and accelerated research globally. It serves as a model for how AI can be developed and deployed in ways that broadly benefit humanity.